These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy. Li T, Gui Y, Yuan T, Liao G, Bian C, Jiang Q, Huang S, Liu B, Wu D. BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360 [Abstract] [Full Text] [Related]
24. Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling. Kristensen H, Thomsen AR, Haldrup C, Dyrskjøt L, Høyer S, Borre M, Mouritzen P, Ørntoft TF, Sørensen KD. Oncotarget; 2016 May 24; 7(21):30760-71. PubMed ID: 27120795 [Abstract] [Full Text] [Related]
25. microRNA expression profile in undifferentiated gastric cancer. Katada T, Ishiguro H, Kuwabara Y, Kimura M, Mitui A, Mori Y, Ogawa R, Harata K, Fujii Y. Int J Oncol; 2009 Feb 24; 34(2):537-42. PubMed ID: 19148490 [Abstract] [Full Text] [Related]
28. miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia-archival samples study. Pełka K, Klicka K, Grzywa TM, Gondek A, Marczewska JM, Garbicz F, Szczepaniak K, Paskal W, Włodarski PK. Histochem Cell Biol; 2021 Mar 24; 155(3):423-433. PubMed ID: 33331954 [Abstract] [Full Text] [Related]
29. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Patnaik SK, Kannisto E, Knudsen S, Yendamuri S. Cancer Res; 2010 Jan 01; 70(1):36-45. PubMed ID: 20028859 [Abstract] [Full Text] [Related]
34. Serum microRNAs as biomarkers in patients undergoing prostate biopsy: results from a prospective multi-center study. Westermann AM, Schmidt D, Holdenrieder S, Moritz R, Semjonow A, Schmidt M, Kristiansen G, Müller SC, Ellinger J. Anticancer Res; 2014 Feb 01; 34(2):665-9. PubMed ID: 24510997 [Abstract] [Full Text] [Related]
35. Expression profile of microRNAs in gastrointestinal stromal tumors revealed by high throughput quantitative RT-PCR microarray. Tong HX, Zhou YH, Hou YY, Zhang Y, Huang Y, Xie B, Wang JY, Jiang Q, He JY, Shao YB, Han WM, Tan RY, Zhu J, Lu WQ. World J Gastroenterol; 2015 May 21; 21(19):5843-55. PubMed ID: 26019448 [Abstract] [Full Text] [Related]
37. miRNA analysis of prostate cancer by quantitative real time PCR: comparison between formalin-fixed paraffin embedded and fresh-frozen tissue. Leite KR, Canavez JM, Reis ST, Tomiyama AH, Piantino CB, Sañudo A, Camara-Lopes LH, Srougi M. Urol Oncol; 2011 May 21; 29(5):533-7. PubMed ID: 19734068 [Abstract] [Full Text] [Related]
39. Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. Kara M, Yumrutas O, Ozcan O, Celik OI, Bozgeyik E, Bozgeyik I, Tasdemir S. Gene; 2015 Aug 01; 567(1):81-6. PubMed ID: 25925209 [Abstract] [Full Text] [Related]
40. Expression profile analysis reveals putative prostate cancer-related microRNAs. Song H, Liu Y, Pan J, Zhao ST. Genet Mol Res; 2013 Oct 24; 12(4):4934-43. PubMed ID: 24301753 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]